| Protocol ID |
|
Title |
|
| MAGRIT 109493 |
|
Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer
Keywords: Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer |
|
| 1199.14 |
|
Multicenter, randomized, double-blind, Phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
Keywords: stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy |
|
| RTOG 0915 |
|
A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer
Keywords: Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer |
|
| RTOG 0813 |
|
Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients
Keywords: Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients |
|
| In-House |
|
Management of Respiratory Organ Motion in Radiation Therapy (Thorax, Abdomen, Breast, Pelvis)
Keywords: radiation therapy |
|
RTOG 0617
NCCTG N0628
CALGB 30609 |
|
A Randomized Phase III Comparison of Standard-Dose (60 Gy) vs. High Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/ Paclitaxel in Patients with Stage IIIA/ IIIB Non-Small Cell Lung Cancer
Keywords: Stage IIIA/ IIIB Non-Small Cell Lung Cancer |
|
| RTOG 0618 |
|
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer
Keywords: Operable Stage I/II Non-Small Cell Lung Cancer |
|
| CALGB 30610/ RTOG 0538 |
|
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
Keywords: Limited Small Cell Lung Cancer |
|
Memorial Sloan Kettering
(also in GI) |
|
A Random Assignment Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) versus Parent DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma
Keywords: Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma |
|
| CALGB 140503 |
|
Phase III Randomized Trial of Lobectomy v. Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer
Keywords: Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer |
|
| ACOSOG Z4033 |
|
A Pilot Study of Radiofrequency Ablation in High-Risk Patients with Stage 1A Non-Small Cell Lung Cancer
Keywords: Stage 1A Non-Small Cell Lung Cancer |
|
| H3E-MC-JMHD |
|
Randomized, Open-Label, Phase III Study of Pemetrexed plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab v. Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer
Keywords: Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer |
|
| H3E-MC-JMIG |
|
Phase III Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin, and Radiotherapy followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectabe, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology
Keywords: Patients with Unresectabe, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology |
|
| RTOG 0436 |
|
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are Treated without Surgery
Keywords: Patients with Esophageal Cancer who are Treated without Surgery |
|
| E1505 |
|
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (>4 cm) -IIIA Non Small Cell Lung Cancer (NSCLC)
Keywords: Completely Resected Stage IB (>4 cm) -IIIA Non Small Cell Lung Cancer (NSCLC) |
|
| RTOG 0972 |
|
A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer
Keywords: Poor-Risk Stage III Non-Small Cell Lung Cancer |